United States
Diffinity Genomics is a biotechnology company founded in 2005, based in the United States. The company focuses on developing proprietary technology for fast and simple nucleic acid isolation and analysis. Their flagship product, the Diffinity RapidTip, offers an innovative approach to purify PCR amplified DNA product in just one minute, in a single step.
The company received their last investment, a Series B round, on June 6th, 2012, with Mass Medical Angels participating as the investor. Diffinity Genomics operates within the industries of biotechnology, healthcare, and life sciences, positioning themselves at the forefront of technology-driven solutions for genetic analysis and isolation.
With their revolutionary products and a track record of attracting investments from reputable organizations, Diffinity Genomics presents a compelling opportunity for potential venture capital consideration, particularly in the rapidly evolving biotechnology and life sciences sectors.
